ARTICLE | Company News
Forma Therapeutics, Cancer Research UK cancer news
March 30, 2015 7:00 AM UTC
Forma and the not-for-profit’s commercial arm, Cancer Research Technology Ltd., launched two virtual companies to develop compounds against undisclosed deubiquitinating enzymes (DUBs) to treat cancer. Forma declined to disclose names of the newcos or financial details. ...